In the melanoma (NPA) cell line, no changes were observed in FOXE1 mRNA, protein expression, and methylation degree after treatment, as we had already observed for the NIS and ABI3 genes (28, 31), probably due to the duration of the treatment or reduced activity of the 5aza demethylating agent in this cell type. The gene discussed is FOXE1; the disease is melanoma.